Perchtoldsdorf, Austria

Brigitte Grohmann

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brigitte Grohmann: Innovator in the Field of Medical Biotechnology

Introduction

Brigitte Grohmann is an accomplished inventor based in Perchtoldsdorf, Austria, known for her significant contributions to medical biotechnology. With two patents to her name, she has made remarkable advancements that are poised to impact the treatment of infections and immunization procedures.

Latest Patents

Her most notable patents include innovative solutions that focus on mutant fragments of outer surface protein A (OspA). These patents detail a polypeptide comprising a mutant fragment of OspA, along with a nucleic acid coding for the same. Additionally, they cover pharmaceutical compositions designed for use as medicaments in methods for treating or preventing infections. Furthermore, her inventions include processes for immunizing subjects, showcasing her dedication to advancing healthcare and disease prevention.

Career Highlights

Brigitte is currently associated with Valneva Austria GmbH, where she engages in groundbreaking research and development efforts. Her work demonstrates a commitment to transforming theoretical concepts into practical solutions, benefiting healthcare and patient treatment options.

Collaborations

In her career, Brigitte has collaborated with esteemed colleagues such as Pär Comstedt and Urban Lundberg. These partnerships reflect the collaborative spirit prevalent in innovative research environments, where shared knowledge and expertise can lead to remarkable developments in biotechnology.

Conclusion

Brigitte Grohmann stands out as a prominent figure in the realm of medical innovations. Her impactful patents and collaborative efforts contribute significantly to the ongoing fight against infections and enhancing immunization strategies. Through her work at Valneva Austria GmbH, she continues to pave the way for future advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…